Abstract:Author(s): Fares-Frederickson, Nancy | Advisor(s): David, Michael | Abstract: Interferon regulatory factor 3 (IRF3) is a transcription factor found in the cytoplasm of most nucleated cells. Upon pathogen detection by pattern recognition receptors, IRF3 becomes activated and translocates to the nucleus where it mediates the production of type I interferon (IFN) and IFN-stimulated genes. The collective actions of these genes induce an antimicrobial state within infected and neighboring cells, allowing for pathogen clearance. Whereas the type I IFN system has been studied extensively in the context of pathogen responses, it has more recently become appreciated for its role in immune cell modulation. In this report we discuss novel findings highlighting the involvement of the type I IFN system—with a focus on IRF3—in T cell development, activation, differentiation, and cytokine production.Using a combination of in vitro assays and in vivo disease models, we demonstrate that IRF3 is a positive regulator of lL-17 and IFN-γ in CD4+ T cells. We show that IRF3-deficient CD4+ T cells have impaired production of the pro-inflammatory cytokines IL-17 and IFN-γ, and are unable to induce disease in the T cell transfer model of colitis. Unexpectedly, we observed IRF3 nuclear translocation in activated T cells. To our knowledge, this is the first description of IRF3 activation following T cell receptor stimulation. These results, which are the focus of chapter 1, reveal a previously unappreciated role for IRF3 in CD4+ T cell responses and extend its role beyond the innate immune response to pathogens.Additionally, we show that type I IFN limits T cell production of IL-2—a cytokine required for T cell activation and expansion—by indirectly altering histone modifications in the IL-2 promoter to retain the locus in an inaccessible configuration. These results, which are the focus of chapter 2, help explain why type I IFN has been an effective treatment for multiple sclerosis—a T cell- mediated autoimmune condition.

TRAF3 enhances type I interferon (IFN I) receptor signaling in T cells through modulation of the phosphatase PTPN22

TRAF3 enhances type I interferon receptor signaling in T cells by modulating the phosphatase PTPN22

TRAF3 regulates the effector function of regulatory T cells and humoral immune responses.

T cell development involves TRAF3IP3-mediated ERK signaling in the Golgi.

Cell Type-Specific Function of TRAF2 and TRAF3 in Regulating Type I IFN Induction

TRAF3 regulates STAT6 activation and T helper cell differentiation by modulating the phosphatase PTP1B

TRAF3 Positively Regulates Host Innate Immune Resistance to Influenza A Virus Infection

The Roles of TRAF3 in Immune Responses.

Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment

Type III interferon exerts thymic stromal lymphopoietin in mediating adaptive antiviral immune response

Beyond Innate Immunity: Defining a Role for Interferon Regulatory Factor 3 in CD4+ T Cell Responses

TRAF1 regulates Th2 differentiation, allergic inflammation and nuclear localization of the Th2 transcription factor, NIP45

The Evolving Role of TRAFs in Mediating Inflammatory Responses

TRAF3 regulation of proximal TLR signaling in B cells

TNF Receptor-Associated Factor-1 (TRAF1) Negatively Regulates Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-beta (Trif)-Mediated Signaling.

TRAF Regulation of IL-17 Cytokine Signaling

Single Amino Acid Substitutions Confer the Antiviral Activity of the TRAF3 Adaptor Protein Onto TRAF5.

NFATC3 promotes IRF7 transcriptional activity in plasmacy--toid dendritic cells.

HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection.

Pathogen Recognition Receptor Signaling Accelerates Phosphorylation-Dependent Degradation of IFNAR1.

Mechanisms of the TRIF-induced Interferon-stimulated Response Element and NF-κB Activation and Apoptosis Pathways